Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boies Schiller Flexner is a premier international law firm recognized for its expertise in high-stakes litigation, white-collar defense, and complex corporate matters. Although not a life sciences company itself, the firm maintains a significant presence in the healthcare and pharmaceutical sectors by representing major industry players in patent litigation, antitrust disputes, and regulatory investigations. Founded in 1997 by David Boies and Jonathan Schiller, the firm has handled some of the most high-profile legal cases in recent history. Its attorneys provide strategic counsel to biotech and pharma clients navigating the intersection of intellectual property law and commercial competition. The firm operates across numerous offices in the United States and Europe, serving a global client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boies Schiller Flexner.